Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Lidocaine for Uterine Artery Resistance in Pre-eclampsia
NCT00848679Phase 3Withdrawn
- Sponsor
- Hadassah Medical Organization
- Start
- Mar 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in preeclampsia, sponsored by Hadassah Medical Organization. Planned start Mar 2009; status: withdrawn.
02
Drugs
lidocaine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT00848679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848679.